Quality of life after radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma: Comparison with transcatheter arterial chemoembolization alone

Quality of Life Research

Volumn 16, Issue 3, 2007, Pages 389-397

  Wang, Yan Bin ^a   Chen, Min Hua ^a   Yan, Kun ^a   Yang, Wei ^a   Dai, Ying ^a   Yin, Shan Shan ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Hepatocellular carcinoma; Quality of life; Radiofrequency ablation; Transcatheter arterial chemoembolization

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CHEMOEMBOLIZATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; INCOME; LIVER CELL CARCINOMA; LIVER FUNCTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RADIOFREQUENCY ABLATION; RANDOMIZED CONTROLLED TRIAL; SOCIAL PSYCHOLOGY; TREATMENT OUTCOME; WELLBEING;

AGED; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHINA; EMBOLIZATION, THERAPEUTIC; FEMALE; HEALTH SURVEYS; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; SICKNESS IMPACT PROFILE; TIME FACTORS;

EID: 33847623796     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11136-006-9133-9     Document Type: Article

References (34)

1. Verhoef C, Visser O, Man RAde, Wilt JHde, IJzermans JN, Janssen-Heijnen ML. Hepatocellular carcinoma in the Netherlands incidence, treatment and survival patterns. Eur J Cancer 2004; 40(10) 1530-1538.
2. Geschwind JF. Chemoembolization for Hepatocellular Carcinoma: Where does the truth lie?. J Vasc Interv Radiol 2002; 13(10) 991-994.
3. Garcea G, Lloyd TD, Aylott C, Maddern G, Berry DP. The emergent role of focal liver ablation techniques in the treatment of primary and secondary liver tumors. Eur J Cancer 2003; 39(15) 2150-2164.
4. Moinpour CM. Measuring quality of life: an emerging science. Semin Oncol 1994; 21(5 Suppl 10) 48-63.
5. Buscarini L, Buscarini E, Stasi MDi. Percutanenous radiofrequncy ablation of small hepatocellular carcinoma: long-term results. Eur Radiol 2001; 11(6) 914-921.
6. Ramsey DE, Kernagis LY, Soulen MC, Geschwind JF. Chemoembolization of Hepatocellular Carcinoma. J Vasc Interv Radiol 2002; 13(9) S211-S221.
7. Zhao JB, Li YH, Chen Y, Zeng QL, He XF, Wei ZH, et al. Evaluation of quality of life before and after interventional therapy in patients with primary hepatocellular carcinoma. Chin J Radiol 2002; 36(10) 873-876.
8. Poon RT, Fan ST, Yu WC, Lam BK, Chan FY, Wong J. A prospective longitudinal study of quality of life after resection of hepatocellular carcinoma. Arch Surgf 2001; 136(6) 693-699.
9. Chow PK, Tai BC, Tan CK, Machin D, Win KM, Johnson PJ, et al. High-dose tamoxifen in the treatment of inoperable hepatocellular carcinoma: A multicenter randomized controlled trial. Hepatology 2002; 36(5) 1221-1226.
10. Chen MH, Yang W, Yan K, Zou MW, Solbiati L, Liu JB, et al. Large liver tumors: Protocol for radiofrequency ablation and its clinical application in 110 patients - Mathematic model, overlapping mode, and electrode placement process. Radiology 2004; 232(1) 260-271.
11. Cheung YB, Thumboo J, Goh C, Khoo KS, Che W, Wee J. The equivalence and difference between the English and Chinese versions of two major, cancer-specific, health-related quality-of-life questionnaires. Cancer 2004; 101(12) 2874-2880.
12. Yu CL, Fielding R, Chan CL, Tse VK, Choi PH, Lau WH, et al. Measuring quality of life of Chinese cancer patients: A validation of the Chinese version of the Functional Assessment of Cancer Therapy-General (FACT-G) scale. Cancer 2000; 88(7) 1715-1727.
13. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the esophagus for bleeding esoghageal varices. Br J Surg 1973; 60(8) 646-649.
14. Higuchi T, Kikuchi M, Okaxaki M. Hepatocellular carcinoma after transcatheter hepatic arterial embolization. A histopathologic study of 84 resected cases. Cancer 1994; 73(9) 2259-2267.
15. Poon RT, Ngan H, Lo CM, Liu CL, Fan ST, Wong J. Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence. J Surg Oncol 2000; 73(2) 109-114.
16. Rossi S, Garbagnati F, Lencioni R, Allgaier HP, Marchiano A, Fornari F, et al. Percutaneous radiofrequncy thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology 2000; 217(1) 119-126.
17. Flechtner H, Bottomley A. Fatigue and quality of life: Lessons from the real world. Oncologist 2003; Supp l1: 5-9.
18. Steineck G, Helgesen F, Adolfsson J, Dickman PW, Johansson JE, Norlen BJ, et al. Quality of life after radical prostatectomy or watchful waiting. N Engl J Med 2002; 347(11) 790-796.
19. Acunas B, Rozanes I. Hepatocellular carcinoma: Treatment with transcatheter arterial chemoembolization. Eur J Radiol 1999; 32(1) 86-89.
20. Gates J, Hartnell GG, Stuart KE, Clouse ME. Chemoembolization of hepatic heoplasms: Safety, complications, and when to worry. Radiographics 1999; 19(2) 399-414.
21. Goldberg SN, Ahmed M. Minimally invasive image-guided therapies for hepatocellular carcinoma. J Clin Gsatroenterol 2002; 35(Suppl 2) S115-S129.
22. Sharif F, Mohebbi S, Tabatabaee H-R, Saberi-Firoozi M, Gholamzadeh S. Effects of psycho-educational intervention on health-related quality of life (QOL) of patients with chronic liver disease referring to Shiraz University of Medical Sciences. Health Qual Life Outcomes 2005; 3: 81-87.
23. Hauser W, Holtmann G, Grandt D. Determinants of health related quality of life in patients with chronic liver diseases. Clin Gastroenterol Hepatol 2004; 2(2) 157-163.
24. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362(9399) 1907-1917.
25. Charnsangavej C, Chuang VP, Wallace S, Soo CS, Bowers T. Angiographic classification of hepatic arterial collaterals. Radiology 1982; 144(3) 485-494.
26. Okazaki M, Yamasaki S, Ono H, Higashihara H, Koganemaru F, Kimura S, et al. Chemoembolotherapy for recurrent hepatocellular carcinoma in the residul liver after hepatectomy. Hepatogastroenterology 1993; 40(4) 320-323.
27. Huang JF, Li SQ, Liang LJ. The effect of transcatheter arterial chemoembolizationin the treatment of hepatocellular carcinoma. Chin J Hepatobiliary Surg 2000; 6(1) 3-6.
28. Takayasu K, Muramatsu Y, Maeda T, Iwata R, Furukawa H, Muramatsu Y, et al. Targeted transarterial oil chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system. AJR Am J Roentgenol 2001; 176(3) 681-688.
29. Solbiati L, Goldberg SN, Ierace T, Ellanoce M, Livraghi T, Gazelle GS. Radio-fraquency ablation of hepatic metastases: postprocedural assessment with a US microbubble contrast agent-early experience. Radiology 1999; 211(3) 643-649.
30. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Ierace T, Solbiati L, et al. Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology 2000; 214(3) 761-768.
31. Buscarini L, Rossi S. Technology for radiofrequency thermal ablation of liver tumors. Semin Laparosc Sur 1997; 4(2) 96-101.
32. Soni MK, Cella D. Quality of Life and Symptom Measures in Oncology: An Overview. Am J Manag Care 2002; 8(18 suppl) S560-S573.
33. Buscarini L, Buscarini E, Distasi M, Quaretti P, Zangrandi A. Percutaneous radiofrequency thermal ablation combined with transcatheter arterial embolization in the treatment of large hepatocellular carcinoma. Ultraschall Med 1999; 20(2) 47-53.
34. Bloomston M, Binitie O, Fraiji E, Murr M, Zervos E, Goldin S, et al. Transcatheter arterial chemoembolization with or without radiofrequency ablation in the management of patients with advanced hepatic malignancy. Am Surg 2002; 68(9) 827-831.